NovaMed will continue as a wholly owned subsidiary of Surgery Partners. Under the terms of the merger agreement, Surgery Partners acquired all of the outstanding shares of NovaMed for $13.25 per share in cash. NovaMed’s stockholders approved the merger at a special meeting on May 4.
The transaction’s closure means NovaMed’s common stock stopped trading on NASDAQ at market close on Wednesday. The common stock will be delisted, and stockholders will soon receive letters of transmittal allowing them to deliver their shares to the paying agent in exchange for payment of the merger consideration.
Read the Sun Herald report on NovaMed and Surgery Partners.
Related Articles on NovaMed:
NovaMed Anticipates May 2011 for Merger With Surgery Partners
56 ASC Management and Development Companies to Watch in 2011
6 Questions to Ask When Adding a New Specialty to a Surgery Center
